No evidence of cardiac, hepatic, or renal toxicity, changes in serum lipids, or clinically relevant changes in laboratory parameters, vital signs, electrocardiograms, or abnormal findings upon physical examinations have been observed
As a result, adverse events may be underreported (73)
above pH 7.0, peptide bond hydrolysis accelerates through base-catalysed nucleophilic attack
SUGGESTED USE Take 1 Servings (1 Scoop) in the morning mix in 8 oz of cold water and take 1 Servings (1 Scoop) in the evening.
The first 30 days establish your baseline tolerance and appetite response, allowing your prescribing clinician to determine whether dose increases are safe and beneficial
However, while the initial findings are promising, more comprehensive clinical trials and research are needed to establish BPC-157's efficacy and safety for these conditions